Published online Feb 6, 2020. doi: 10.12998/wjcc.v8.i3.540
Peer-review started: November 26, 2019
First decision: December 23, 2019
Revised: December 30, 2019
Accepted: January 8, 2020
Article in press: January 8, 2020
Published online: February 6, 2020
Processing time: 71 Days and 22 Hours
Due to a shortage of donor kidneys, many centers have utilized graft kidneys from brain-dead donors with expanded criteria. Kidney transplantation (KT) from donors on extracorporeal membrane oxygenation (ECMO) has been identified as a successful way of expanding donor pools. However, there are currently no guidelines or recommendations that guarantee successful KT from donors undergoing ECMO treatment. Therefore, acceptance of appropriate allografts from those donors is solely based on clinician decision.
We report a case of successful KT from a brain-dead donor supported by ECMO for the longest duration to date. A 69-year-old male received a KT from a 63-year-old brain-dead donor who had been on therapeutic ECMO treatment for the previous three weeks. The recipient experienced slow recovery of graft function after surgery but was discharged home on post-operative day 17 free from hemodialysis. Allograft function gradually improved thereafter and was comparatively acceptable up to the 12 mo follow-up, with serum creatinine level of 1.67 mg/dL.
This case suggests that donation even after long-term ECMO treatment could provide successful KT to suitable candidates.
Core tip: Graft kidneys from expanded criteria donors have been utilized following shortage of donor kidneys. Kidney transplantation (KT) from extracorporeal membrane oxygenation (ECMO) donors has been successful. However, limited data on clinical outcomes after KT from ECMO donors left acceptance of these marginal kidneys solely to clinicians. We report a rare case of successful KT from a brain-dead donor who had been supported with therapeutic ECMO for three weeks before the donation. This strongly suggests that expanded criteria donors’ kidneys, even after a donor has been on ECMO for a relatively long duration, can provide favorable outcomes in well-selected recipients.